Angiokeratoma in Fabry Disease: Diagnostic but not Treatment Effectiveness Marker
<p><strong>Introduction:</strong> Fabry disease (FD) is a rare metabolic disorder that leads to severe morbidity and premature mortality as a result of cardiac, renal or cerebrovascular complications. Enzyme replacement therapy (ERT) has been shown to provide clinically important b...
Saved in:
Main Authors: | Jelena Roganovic (Author), Ingeborg Barisic (Author), Nives Jonjic (Author), Ksenija Fumic (Author), Ana Dordevic (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2014-10-15.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genital angiokeratoma in a woman with Fabry disease: the dermatologist's role
by: Patricia Moraes Resende de Jesus, et al.
Published: (2018) -
Fabry's disease manifesting as familial angiokeratoma corporis diffusum in an indian family - A rare occurrence!
by: Ishmeet Kaur, et al.
Published: (2020) -
Bone Marrow Burkitt Lymphoma in a Child
by: Matija Knežić, et al.
Published: (2020) -
Doença de Fabry Fabry disease
by: Paula Boggio, et al.
Published: (2009) -
Echocardiographic markers of left ventricular hypertrophy and concentric remodeling - limitations in diagnostics of cardiac amyloidosis, Fabry disease and hypertrophic cardiomyopathy
by: Judyta Znamirowska, et al.
Published: (2024)